Cristina Alba

1.0k total citations
22 papers, 502 citations indexed

About

Cristina Alba is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Cristina Alba has authored 22 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 13 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Cristina Alba's work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (11 papers) and Tuberculosis Research and Epidemiology (3 papers). Cristina Alba is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Microscopic Colitis (11 papers) and Tuberculosis Research and Epidemiology (3 papers). Cristina Alba collaborates with scholars based in Spain and Portugal. Cristina Alba's co-authors include Carlos Taxonera, David Olivares, Enrique Rey, Íñigo Sagastagoitia, Juan L. Mendoza, Manuel Díaz‐Rubio, Raquel Martins Lana, Carmen Martín, Ángel Ponferrada and Ramón Pajares and has published in prestigious journals such as Gastroenterology, European Heart Journal and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Cristina Alba

21 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cristina Alba Spain 10 326 238 141 104 99 22 502
Gianluca Andrisani Italy 15 390 1.2× 346 1.5× 95 0.7× 220 2.1× 85 0.9× 48 721
Olga Merino Spain 14 512 1.6× 460 1.9× 106 0.8× 225 2.2× 106 1.1× 32 734
Gili Focht Israel 14 464 1.4× 316 1.3× 183 1.3× 227 2.2× 87 0.9× 53 694
Jong Wook Kim South Korea 15 318 1.0× 361 1.5× 50 0.4× 308 3.0× 196 2.0× 56 770
Annemarie C. de Vries Netherlands 15 436 1.3× 328 1.4× 52 0.4× 293 2.8× 126 1.3× 73 730
Lone Larsen Denmark 12 165 0.5× 114 0.5× 65 0.5× 133 1.3× 49 0.5× 36 442
Samuel Fernandes Portugal 13 349 1.1× 326 1.4× 33 0.2× 269 2.6× 79 0.8× 60 604
Luís Correia Portugal 14 509 1.6× 417 1.8× 37 0.3× 220 2.1× 64 0.6× 52 705
J.‐F. Rahier Belgium 8 166 0.5× 160 0.7× 53 0.4× 114 1.1× 61 0.6× 14 446
Kristin Kaasen Jørgensen Norway 14 218 0.7× 271 1.1× 45 0.3× 185 1.8× 28 0.3× 35 577

Countries citing papers authored by Cristina Alba

Since Specialization
Citations

This map shows the geographic impact of Cristina Alba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Alba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Alba more than expected).

Fields of papers citing papers by Cristina Alba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina Alba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Alba. The network helps show where Cristina Alba may publish in the future.

Co-authorship network of co-authors of Cristina Alba

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina Alba. A scholar is included among the top collaborators of Cristina Alba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina Alba. Cristina Alba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taxonera, Carlos, et al.. (2025). Real-World Effectiveness and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 14(7). 2232–2232.
2.
Taxonera, Carlos, et al.. (2024). Darvadstrocel for complex perianal fistulas in Crohn's disease: A systematic review and meta‐analysis. United European Gastroenterology Journal. 13(3). 416–426. 1 indexed citations
3.
Aparicio‐Puerta, Ernesto, Carmen Griñán‐Lisón, Gema Jiménez, et al.. (2023). Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma. Cancers. 15(14). 3666–3666. 5 indexed citations
4.
Taxonera, Carlos, et al.. (2023). Meta‐analysis: Real‐world effectiveness and safety of ustekinumab in patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics. 57(6). 610–619. 24 indexed citations
5.
Taxonera, Carlos, María Jesús Fernández‐Aceñero, David Olivares, et al.. (2022). Association of golimumab trough concentrations during maintenance with clinical, biological, endoscopic and histologic remission in patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics. 56(4). 614–624. 3 indexed citations
6.
Taxonera, Carlos, David Olivares, & Cristina Alba. (2021). Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis. Inflammatory Bowel Diseases. 28(1). 32–40. 95 indexed citations
7.
Taxonera, Carlos, Manuel Barreiro‐de Acosta, Isabel Vera, et al.. (2021). Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study. Therapeutic Advances in Gastroenterology. 14. 1088239133–1088239133. 1 indexed citations
8.
Taxonera, Carlos, et al.. (2020). 2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics. 52(2). 276–283. 115 indexed citations
9.
Taxonera, Carlos, et al.. (2020). Recurrent granulomatous cheilitis associated with Crohn’s disease successfully treated with ustekinumab: case report and literature review. Therapeutic Advances in Gastroenterology. 13. 3974123191–3974123191. 9 indexed citations
10.
Taxonera, Carlos, et al.. (2020). Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures. Inflammatory Bowel Diseases. 27(6). 864–869. 27 indexed citations
11.
Taxonera, Carlos, et al.. (2020). Can COVID-19 Trigger De Novo Inflammatory Bowel Disease?. Gastroenterology. 160(4). 1029–1030. 18 indexed citations
12.
Olivares, David, et al.. (2019). Differences in the need for adalimumab dose optimization between Crohn�s disease and ulcerative colitis. Revista Española de Enfermedades Digestivas. 111(11). 846–851. 6 indexed citations
13.
Taxonera, Carlos, Marisa Iborra, Marta Maia Boscá-Watts, et al.. (2019). Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis. Current Medical Research and Opinion. 35(7). 1297–1304. 13 indexed citations
14.
Sánchez‐Ramón, Silvia, et al.. (2018). Reliability evaluation of four different assays for therapeutic drug monitoring of infliximab levels. Therapeutic Advances in Gastroenterology. 11. 3971972477–3971972477. 14 indexed citations
15.
Sánchez‐Ramón, Silvia, Juan L. Mendoza, Cristina Alba, et al.. (2016). Sa1955 Comparison of Four Assay Kits for Measuring Infliximab Trough Levels and Antibodies to Infliximab in Patients With Inflammatory Bowel Disease. Gastroenterology. 150(4). S415–S415. 2 indexed citations
16.
Taxonera, Carlos, Eva Iglesias, Fernándo Muñoz, et al.. (2016). Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation. Digestive Diseases and Sciences. 62(2). 481–490. 35 indexed citations
17.
Taxonera, Carlos, Manuel Barreiro‐de Acosta, Marta Calvo, et al.. (2015). Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis. Digestive Diseases and Sciences. 60(10). 3075–3084. 26 indexed citations
18.
Alba, Cristina, et al.. (2013). Natural Ventilation and Ground Cooling to Improve Thermal Comfort Conditions of Workers in an Industrial Building. 1 indexed citations
19.
Mendoza, Juan L., Carlos Taxonera, Raquel Martins Lana, et al.. (2005). Diagnostic and treatment recommendations on perianal Crohn's disease. Revista Española de Enfermedades Digestivas. 97(1). 46–56. 3 indexed citations
20.
Mendoza, Juan L., et al.. (2005). Manifestaciones extraintestinales en la enfermedad inflamatoria intestinal: diferencias entre la enfermedad de Crohn y la colitis ulcerosa. Medicina Clínica. 125(8). 297–300. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianluca Andrisani Breakdown of academic impact, for papers by Olga Merino Breakdown of academic impact, for papers by Gili Focht Breakdown of academic impact, for papers by Jong Wook Kim Breakdown of academic impact, for papers by Annemarie C. de Vries Breakdown of academic impact, for papers by Lone Larsen Breakdown of academic impact, for papers by Samuel Fernandes Breakdown of academic impact, for papers by Luís Correia Breakdown of academic impact, for papers by J.‐F. Rahier Breakdown of academic impact, for papers by Kristin Kaasen Jørgensen
Rankless by CCL
2026